This identifies HDAC3 as a lineage-specific ferroptosis regulator in CRC, contrasting with its pro-ferroptotic role reported in other cancer types such as hepatocellular carcinoma or glioblastoma. This evidence concerns the gene HDAC3 and hepatocellular carcinoma.